NCGS, Inc. is a global contract research organization providing a full scope of services needed to successfully plan and conduct all phases of pharmaceutical, biologic, device, and novel diagnostic clinical trials.  NCGS has been in operation since 1984 utilizing a customer, site and patient centric approach to study delivery that leverages technology innovation to make timely data-derived decisions.  NCGS offers only highly experienced staff with a mean industry tenure of 15 years.  Headquartered in Charleston, South Carolina, USA and spanning the US and EU, NCGS has contributed to the approval of 58 products while maintaining a spotless record of zero 483s/regulatory findings in 33 years of operation. NCGS continues to build its reputation with continued focus on integrating high quality technology, staff and processes to provide our Sponsors, sites, and patients with best possible results. NCGS focuses primarily on complex areas of clinical development – oncology-hematology, infectious disease and critical care, CNS (mood, movement, pain and cognition) in both adult and pediatric populations.  The universal hope for a cure drives NCGS to deliver high quality results time and again.

Visit Website


  • APAC
  • Australia
  • Europe
  • North America

Therapeutic Areas

  • Bone / Osteoporosis
  • Cardiovascular
  • CNS
  • Dental and Oral Health
  • Dermatology
  • Diabetes
  • Endocrinology
  • Gastroenterology
  • Genetic Diseases
  • Hematology
  • Hepatology
  • Immunology
  • Infectious Diseases
  • Inflammation
  • Internal Diseases
  • Metabolic Diseases
  • Musculoskeletal
  • Nephrology
  • Neurology
  • Obstetrics / Gynecology
  • Oncology
  • Ophthalmology
  • Orthopedics
  • Otolaryngology/ENT (Ear/Nose/Throat)
  • Pediatrics / Neonatology
  • Pharmacology / Toxicology
  • Psychiatry
  • Pulmonary
  • Respiratory
  • Rheumatology
  • Surgery
  • Thrombosis
  • Urology
  • Vaccines